Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4165385

N#C[C@H]1CSCN1C(=O)[C@@H](N)Cc1c[nH]c2ccc([N+](=O)[O-])cc12.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 5/20 0.47
PTPRA P18433 1/20 0.46
DPP7 Q9UHL4 3/20 0.45
FAP Q12884 3/20 0.45
CYP2C19 P33261 1/20 0.45
DPP8 Q6V1X1 3/20 0.44
DPP9 Q86TI2 3/20 0.44
NQO2 P16083 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
HTR1A P08908 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
NFKB1 P19838 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4179156 0.94 DPP4 (0.49) DPP4PTPRADPP7FAPCYP2C19
SCHEMBL4179160 0.94 DPP4 (0.49) DPP4PTPRADPP7FAPCYP2C19
SCHEMBL4104230 0.94 DPP4 (0.49) DPP4PTPRADPP7FAPCYP2C19
SCHEMBL13803968 0.86 DPP4 (0.46) DPP4PTPRADPP7FAPCYP2C19
Trifluoroacetic Acid SCHEMBL4163377 0.86 DPP4 (0.64) DPP4DPP7FAPDPP8DPP9
SCHEMBL13814280 0.86 DPP4 (0.46) DPP4PTPRADPP7FAPCYP2C19
SCHEMBL4172278 0.82 DPP4 (0.41) DPP4PTPRADPP7FAPCYP2C19
SCHEMBL4172280 0.82 DPP4 (0.41) DPP4PTPRADPP7FAPCYP2C19
SCHEMBL4177995 0.82 DPP4 (0.41) DPP4PTPRADPP7FAPCYP2C19
SCHEMBL13803966 0.82 DPP4 (0.41) DPP4PTPRADPP7FAPCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149504-A1 Novel 5-Substituted Indole Derivatives As Dipeptidyl Peptidase IV (DPP-IV) Inhibitors AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2009-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149504-A1 Novel 5-Substituted Indole Derivatives As Dipeptidyl Peptidase IV (DPP-IV) Inhibitors DPP4, DPP3, DPP7 DPP4 1/4885PTPRA 768/4885DPP7 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.